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ARALAR/AGC1/Slc25a12, the aspartate-glutamate carrier frombrainmitochondria, is the regulatory step in themalate-aspartateNADH
shuttle, MAS. MAS is used to oxidize cytosolic NADH inmitochondria, a process required to maintain oxidative glucose utilization. The
role of ARALAR was analyzed in two paradigms of glutamate-induced excitotoxicity in cortical neurons: glucose deprivation and acute
glutamate stimulation.ARALARdeficiencydidnot aggravate glutamate-inducedneuronal death in vitro, althoughglutamate-stimulated
respiration was impaired. In contrast, the presence of L-lactate as an additional source protected against glutamate-induced neuronal
death in control, but not ARALAR-deficient neurons. L-Lactate supplementation increased glutamate-stimulated respiration partially
prevented the decrease in the cytosolic ATP/ADP ratio induced by glutamate and substantially diminishedmitochondrial accumulation
of 8-oxoguanosine, a marker of reactive oxygen species production, only in the presence, but not the absence, of ARALAR. In addition,
L-lactate potentiated glutamate-induced increase in cytosolic Ca2, in a way independent of the presence of ARALAR. Interestingly, in
vivo, the loss of half-a-dose of ARALAR in aralar/mice enhanced kainic acid-induced seizures and neuronal damage with respect to
control animals, in a model of excitotoxicity in which increased L-lactate levels and L-lactate consumption have been previously proven.
These results suggest that, in vivo, an inefficient operation of the shuttle in the aralar hemizygous mice prevents the protective role of
L-lactate on glutamate excitotoxiciy and that the entry and oxidation of L-lactate through ARALAR-MAS pathway is required for its
neuroprotective function.
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Introduction
L-Glutamate, the major excitatory neurotransmitter in the CNS,
plays an important role in neuronal differentiation, migration,
and survival in the developing brain, largely through facilitating
Ca2 entry (Hack and Bala´zs, 1994; Yano et al., 1998).
Glutamate activates postsynaptic receptors, such as iono-
tropic AMPA or NMDA and metabotropic receptors (Farooqui
and Farooqui, 2009), allowing the influx of Ca2 and Na and
the release of Ca2 from intracellular compartments. Increased
neuronal activity imposed by glutamate has been shown to up-
regulate respiration in neurons (Jekabsons and Nicholls, 2004;
Gleichmann et al., 2009). Excessive activation of glutamate recep-
tors can also evoke neuronal dysfunction, damage, or death
through glutamate excitotoxicity (Choi, 1988; Wang and Qin,
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Significance Statement
Lactate now stands as a metabolite necessary for multiple functions in the brain and is an alternative energy source during
excitotoxic brain injury. Here we find that the absence of a functional malate-aspartate NADH shuttle caused by aralar/AGC1
disruption causes a block in lactate utilization by neurons, which prevents the protective role of lactate on excitotoxicity, but not
glutamate excitotoxicity itself. Thus, failure to use lactate is detrimental and is possibly responsible for the exacerbated in vivo
excitotoxicity in aralar/mice.
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2010), which is involved in acute or
chronic neurodegenerative processes.
Mitochondrial Ca2 plays a key role in
glutamate excitotoxicity, and preventing
Ca2 uptake by mitochondria protects
against neuronal death (Stout et al., 1998;
Qiu et al., 2013). Another important
player is poly(ADP ribose)polymerase-1
(PARP-1), which is activated by DNA
strand breaks, and its detrimental role in
excitotoxicity has been attributed to
PARP1-mediated NAD loss and PAR
synthesis, which blocks glycolysis and
leads to ATP loss (Zhang et al., 1994;
Alano et al., 2010). Other sources of
NAD depletion, including SARM1 pro-
tein, an essential mediator of axonal de-
generation (Gerdts et al., 2015), may also
play a role.
These two types of glutamate actions,
physiological and excitotoxic, may be in-
fluenced by the nutrients used by neu-
rons. Glucose is the principal energy
source of the adult brain (Sokoloff, 1992).
It can be stored as glycogen mainly by as-
trocytes or broken down to pyruvate in
glycolysis. L-Lactate is a common metab-
olite between glycolysis and oxidative
phosphorylation, and it is considered a
preferred fuel for brain metabolism
(Smith et al., 2003). Neural activity is also
accompanied by an acute rise in tissue
L-lactate (Prichard et al., 1991; Hu and Wilson, 1997; Barros,
2013). L-Lactate has been shown to rescue from neuronal cell
death during ischemic-related processes both in vitro (Schurr et
al., 1997a, b, 2001a; Maus et al., 1999; Berthet et al., 2009) and in
vivo (Ros et al., 2001; Schurr et al., 2001b; Berthet et al., 2009).
Whether andwhenneurons produce or consume L-lactate during
neural activity remains a controversial issue (San Martín et al.,
2013). Some effects of L-lactate cannot be interpreted as a fuel,
which suggests that L-lactate has intercellular signaling functions.
G-protein-coupled L-lactate receptor, GPR81, was found in the
mammalian brain and downregulates cAMP levels (Lauritzen et
al., 2014). Indeed, the neuroprotective effect of lactate in vivo
probably occurs both through a receptor-mediated signal trans-
duction and also by the classic metabolic pathway as an alterna-
tive source of energy (Castillo et al., 2015).
In neurons, glucose oxidation or intracellular use of L-lactate by
mitochondria requires an NADH shuttle system. The malate-
aspartate NADH shuttle (MAS) is the main shuttle in brain (Satru´-
stegui et al., 2007), and its regulatorycomponent isARALAR/AGC1/
Slc25a12, the mitochondrial transporter of aspartate–glutamate.
ActivationofARALAR-MASby extramitochondrial Ca2 in the nM
range results in an increase inNADHproduction in neuronalmito-
chondria (Pardoet al., 2006).Ca2 activationofARALAR-MASwill
function to “push” pyruvate into mitochondria by increasing: (1)
the cytosolic redox state of NAD/NADH, (2) the conversion of lac-
tate into pyruvate, and (3) glucose oxidation (Fig. 1).
The expression of aralar is regulated by active, phosphory-
lated CREB protein and by signal pathways that modify the ac-
tivity of CREB itself, including intracellular Ca2 levels (Menga
et al., 2015). Ca2 activation of ARALAR increases pyruvate for-
mation and supply into mitochondria, which increases mito-
chondrial matrix NADH production and respiration. Moreover,
the ARALAR-MAS pathway is required to upregulate respiration
under conditions of increasedworkload in neurons using glucose
(Llorente-Folch et al., 2013; Rueda et al., 2014).
Both glucose and L-lactate require ARALAR-MAS for oxida-
tion. Glutamate imposes a strong workload in neurons, suggest-
ing that ARALAR-MAS may be required for the physiological
response to glutamate and also in response to excitotoxicity. In
the present work, we have addressed the requirement of the shut-
tle in physiological and excitotoxic conditions triggered by gluta-
mate with different nutrients and using aralar KO mice.
Materials andMethods
Animals. Male SVJ129  C57BL/6 mice carrying a deficiency for aralar
expression (aralar/, aralar /, and aralar /) obtained from Lexi-
con Pharmaceuticalswere used (Jalil et al., 2005). Themicewere housed in a
humidity- and temperature-controlled room on a 12 h light/dark cycle, re-
ceiving water and food ad libitum. All animal procedures were approved by
the corresponding institutional ethical committee (Centro de BiologíaMo-
lecular SeveroOchoa) andwere performed in accordance with Spanish reg-
ulations (BOE 67/8509-12, 1988) and European regulations (EU directive
86/609, EU decree 2001-486). All efforts were made to minimize animal
suffering. Reporting followed the ARRIVE Guidelines.
Neuronal cell culture. Cortical neuronal cultures were prepared from
E15-E16 mouse embryos as described previously (Ramos et al., 2003;
Pardo et al., 2006). Embryoswere obtained from crosses betweenC57BL/
6SV129 aralar/mice, and nonbrain tissue was used for determination
of DNA genotype as previously described for aralar (Jalil et al., 2005;
Pardo et al., 2006). Neurons represented80% of the total cell popula-
tion (Ramos et al., 2003; Pardo et al., 2006).
Viability assay. In glucose deprivation assays, cellular viability was
evaluated 24 h after maintaining cultures for 6 h in conditions of: nor-
moglycemia (5.0 mM glucose), glucose deprivation (nominally 0.0 mM
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Figure 1. Schematic representation of the malate-aspartate NADH shuttle involvement in glucose oxidation and L-lactate
utilization. Extramitochondrial Ca 2 activation of ARALAR-MASwill function to “push” pyruvate intomitochondria by increasing
the cytosolic redox state of NAD/NADH both by promoting glucose oxidation and the conversion of lactate into pyruvate. Aralar/
AGC, mitochondrial aspartate/glutamate carrier; OGC, KG/malate carrier; PyrC, mitochondrial pyruvate carrier. cMDH, mMDH,
cytosolic and mitochondrial malate dehydrogenases; cAAT, mAAT, cytosolic and mitochondrial aspartate amino transferases.
4444 • J. Neurosci., April 20, 2016 • 36(16):4443–4456 Llorente-Folch et al. • Aralar/AGC1 Required for L-Lactate-Mediated Neuroprotection in Excitotoxicity
glucose), or 10 mM L-lactate. In glutamate administration assays, 5–50
Mwas added inMEMfor 5 or 30min.Culturesweremaintained for 24 h
in fresh serum-free B27-supplemented Neurobasal medium until testing
the cellular viability. When used, L-lactate (10 mM) was added 30 min
before the experiment andwas present during glutamate stimulation and
in the subsequent fresh media. CL/PI treatment was performed as previ-
ously described (Mattson et al., 1995).
Measurement of glutamate release. The concentration of L-glutamic
acid in cell-free supernatants wasmeasured by an enzymatic assay (Lund
and Bergmeyer, 1986). Briefly, cell supernatants from each condition
were collected and used after deproteinization (5%PCA)-neutralization.
Each media sample was mixed with Tris/hydrazine buffer (Tris 0.1 M,
EDTA2mM, hydrazine 0.63M, pH9). The enzymatic reactionwas started
by addition of glutamic dehydrogenase (14 IU/ml). L-Glutamate suffers
an oxidative deamination to 2-oxoglutarate in the presence of NAD
and glutamic dehydrogenase, with the corresponding NADH formation.
The increase in NADH concentration, measured by the change in absor-
bance at 340 nm by microplate reader (FLUOstar OPTIMA, BMG Lab
Tech), is proportional to the amount of glutamate. Concentrations of
glutamate in the experimental samples were calculated according to the
optical densities obtained from standards of glutamate solution. The
amount of glutamate produced by cells was calculated after subtracting
the values obtained from wells containing distilled water.
Cytosolic Na and Ca2 imaging in primary neuronal cultures. Single-
cell measurements of cytosolic Ca2 and Na were performed as previ-
ously described (Llorente-Folch et al., 2013) using neurons loaded with
fura-2 AM as Ca2 indicator (Ruiz et al., 1998; Pardo et al., 2006) and
SBFI as Na indicator (Rose and Ransom, 1997) at 37°C. Experiments
were performed in HEPES-control salt solution (HCSS) containing 15
mM glucose with 2 mM CaCl2. Image acquisition was performed with the
Aquacosmos 2.5 software (Hamamatsu), and data analysis was donewith
Origin software (Origin-Lab).
Measurement of cytosolic pH. Cytosolic pH was measured with the
fluorescent probe 2, 7-bis (2-carboxyethyl)-5(6)-carboxy-fluorescein
(BCECF; Invitrogen). Neurons growing on poly-lysine-coated coverslips
were incubated in HCSS with 15mM glucose and 2mMCaCl2 containing
0.12M BCECF-AM and 0.025% pluronic F.127 (Invitrogen) for 30min
at 37°C, and rinsed in HCSS for 20 min before use. Then coverslips were
mounted on the microscope stage equipped with a 40 objective as
described previously (Ruiz et al., 1998), and BCECF fluorescence was
imaged ratiometrically using alternate excitation at 450 and 490 nm, and
a 530 nm emission filter with a Neofluar 40/0.75 objective in an Axio-
vert 75Mmicroscope (Zeiss). Additions weremade as a bolus. For single-
cell analysis of pHi, the ratio of fluorescence intensity at 450 nm (F(450))
and 490 nm (F(490)), (F(450)/F(490)), was obtained. Image acquisition
was performed with the Aquacosmos 2.5 software (Hamamatsu), and
data analysis was done with Origin software (Origin-Lab).
Imaging of mitochondrial Ca2 and cytosolic ATP/ADP ratio in primary
neuronal cultures. Single-cellmeasurements of cytosolic ATP/ADP ratio and
mitochondrial Ca2 were performed in neurons transfected using calcium
phosphate protocol 24 or 48 h before the experiments either with the plas-
mid coding for cytosolic targeted ratiometric Perceval-HR (Tantama et al.,
2013) or with the plasmid genetically encoded chameleon probe specifically
targeted into mitochondria 4mitD3cpv (Palmer and Tsien, 2006). Neurons
were seeded in chambered coverglass 4-well plates at a density of 105 cell/
cm2 and at 8–9 DIV were transfected. Experiments were performed in
HCSS, 15 mM glucose with 2 mM CaCl2. When used, 2 mM L-lactate was
added immediately before starting the experiment.
Briefly, cells were excited for 100 ms alternatively at 426-44 (Venus)
and 472-27 (GFP) for Perceval-HRmeasurements and for 40ms at 440
10 nm (440AF21, Omega Optical) for mit4D3cpv. The emitted fluores-
cence was collected at 520/35 (GFP) for Perceval HR probe and through
480 at 535 nm for mit4D3cpv. Images were collected every 5 s using a
filter wheel (Lambda 10-2, Sutter Instruments, all filters purchased from
Chroma) and recorded by a Hamamatsu C9100-02 camera mounted on
an Axiovert 200M inverted microscope equipped with a 40/1.3 Plan-
Neofluar objective.
Perceval-HR emission ratio was GFP/CFP, whereas mit4D3cpv emis-
sion ratio was YFP/CFP, reflecting cytosolic ATP/ADP ratio and mito-
chondrial Ca2, respectively. Single-cell fluorescence recordings were
analyzed using ImageJ (National Institutes of Health) or MetaMorph
(Universal Imaging).
Measurement of cellular oxygen consumption. Cellular oxygen con-
sumption rate (OCR) was measured using a Seahorse XF24 Extracellular
Flux Analyzer (Seahorse Bioscience) (Qian and Van Houten, 2010) as
previously described (Llorente-Folch et al., 2013). Cells were equilibrated
with bicarbonate-free low-buffered DMEM (without pyruvate, L-lactate,
glucose, glutamine, and Ca2) supplemented with 2.5 mM glucose and 2
mM CaCl2 for 1 h before XF assay. Additional substrates apart from
glucose (i.e., 2 mM L-lactate and 2 mM pyruvate) were prepared in the
experimental buffer and were incubated with the neurons 30 min before
the XF assay and maintained throughout the experiment.
Mitochondrial function in neurons was determined through se-
quential addition of 6M oligomycin (Oli), 0.5 mM 2,4-dinitrophenol
(DNP), and 1 M antimycin/1 M rotenone. This allowed determina-
tion of basal oxygen consumption, oxygen consumption linked to
ATP synthesis (ATP), non-ATP linked oxygen consumption (leak),
mitochondrial uncoupled respiration, and nonmitochondrial oxygen
consumption (Qian and VanHouten, 2010) for review see (Brand and
Nicholls, 2011).
Membrane potential. Cells were loaded with 10 g/ml Rhod-123 (In-
vitrogen) for10–15 min at room temperature. Rhod-123 fluorescence
was excited at 488 nm and measured at 530 nm (Emaus et al., 1986;
Duchen et al., 1990). Mitochondrial potential (	mit) was evaluated
by measuring Rhod-123 fluorescence quench using the FLUOStart
OPTIMA (BGM Labtech) spectrofluorometer. Mitochondrial depolar-
ization increases the fluorescence signal, andwe analyzed the effect of 100
M glutamate. Uncoupling agents (0.5mMDNP) increased fluorescence,
whereas fluorescence was reduced by blockade of the Fo proton channel
of the mitochondrial ATP synthase complex (6 M oligomycin). Exper-
iments were performed in the presence of 2mMCa2 or in the absence of
Ca2 with 100 M EGTA. We have presented all data as a ratio F/Fo
referring the changes in fluorescence to the baseline level before gluta-
mate addition.
Immunodetection of 8-hydroxy-2-deoxiguanosine (8-OHdG). Immu-
nodetection assays of 8-OHdG were performed as described previously
(Soultanakis et al., 2000). Four different groups were established. Con-
trol group (CTR) only suffered the replacement of the media like the
others, in L-lactate group (Lac) neurons were incubated with 10 mM
L-lactate for 30 min, the glutamate group (Glu) was stimulated with 100
M glutamate for 30 min in MEM and the glutamate  L-lactate group
(GluLac), where cells were preincubated with L-lactate before the exci-
totoxic stimulus. Anti-8-oxo-dG immunostaining assay was performed
according to the manufacturer’s protocol from Trevigen.
Confocal scanning lasermicroscopywas performed in a confocal Zeiss
microscope with 63 oil-immersion objective. The analysis was per-
formed in individual cells, and intensity thresholds were set that high-
lighted the areas to correspond to nucleus and mitochondria (from
TOPRO-3 and Mn-SOD labeling). With these thresholds (nuclear 500-
1999, andmitochondrial 2000-16383), we have analyzed-8-OHdG flu-
orescence measuring the average intensity (considering constant nuclear
area) and integrated intensity (considering the perinuclear area occupied
bymitochondria). Image analysis was performed withMetaMorph 5.0r7
(Universal Imaging).
Kainic acid (KA) treatment, seizure induction, and quantification of
degenerating neurons.KA (22.5mg/kg; Sigma-Aldrich), freshly prepared,
was administered intraperitoneally to 3-month-oldmalewild-type (WT)
and aralar hemizygous (HT) mice (n
 13 mice for each genotype). An
initial treatment of 15 mg/kg KA was reinforced with half of the initial
dose 1 h later. This sublethal dose of KA induced continuous tonic clonic
seizures and at least one episode of Level 4 (Table 1). Seizure severity was
quantified in a blind manner using the previously established 6 point
seizure scale (Schauwecker and Steward, 1997) adapted from a 5 point
scale for rat (Racine, 1972) (Table 1).
One week after the treatment, animals were intracardially perfused
with saline buffer (0.9% NaCl in PBS) and 4% PFA (in 0.1 M phosphate
buffer, pH 7.4). Brains were removed, postfixed for 24 h in 4% PFA at
4°C, and transferred into sucrose (30% sucrose in 0.1 M phosphate buf-
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fer) 48 h at 4°C. Coronal sections were cut with a freezing cryotome
(free-floating sections) and kept in cryoprotectant solution (25% glyc-
erol, 25% ethylene glycol in 50 mM PB) at 20°C until processing.
Fluoro-Jade B dye (Millipore) was used for the detection of neuronal
degeneration as previously described (Schmued et al., 1997). Sections
were examined with a confocal Zeiss microscope with a 10 objective.
Image analysis was performed with the ImageJ program. The analysis
shows the total number of degenerating (Fluoro Jade B-positive) neu-
rons in a subfield referred to the area of the corresponding hippocampal
subfield. Each tissue section was also examined for neurodegeneration in
other brain regions, including neocortex, striatum, thalamus, and
amygdala, to obtain a qualitative assessment of a strain’s pattern of neu-
ronal cell death throughout the brain (Table 2).
Results
Stimulation of respiration in response to glutamate is
impaired in ARALAR-deficient neurons
Glutamate (100 M) activates ionotropic NMDA and AMPA re-
ceptors, and metabotropic receptors, and induced a pronounced
rise in cytosolic Ca2 in cerebral cortex neurons (Fig. 2A–C),
which was prevented in Ca2-free media (data not shown). It
also induced a sustained rise in mitochondrial Ca2 levels (Fig.
2D), as reported by mit4D3cpv, a genetically encoded Ca2 sen-
sor expressed in the mitochondrial matrix (Jean-Quartier et al.,
2012), which did not vary with ARALAR deficiency (Fig. 2E,F)
and a prominent loss of mitochondrial membrane potential as
estimated from rhodamine 123 fluorescence, which was blocked
in Ca2-free media (Fig. 2G). NMDA receptors also transport
Na; and even though a typical NMDA receptor may have a 10:1
selectivity for Ca2 over Na (Mayer and Westbrook, 1987;
Nicholls, 2008), the higher concentration of the latter leads to a
Na flux that can greatly exceed that of Ca2. The increase in
cytoplasmic Na concentration caused by glutamate was mea-
sured in neurons loaded with the Na indicator SBFI-AM (Rose
and Ransom, 1997) and was not affected by ARALAR deficiency
(Fig. 2H). Thus, except for a slightly smaller glutamate-induced
cytosolic calcium peak (Fig. 2C), ionic fluxes induced by gluta-
mate were the same in control and ARALAR-deficient neurons.
The glutamate-induced ionic unbalance results in a net in-
crease in ATP consumption to extrude Ca2 and Na and in
stimulation of mitochondrial respiration to match the increased
ATP demand (Nicholls et al., 2003; Jekabsons and Nicholls,
2004). As previously described (Llorente-Folch et al., 2013), basal
OCR in aralar-KO neuronal cultures was severely reduced (Fig.
2I), indicating that the lack of MAS prevents adequate glucose-
derived substrate supply tomitochondria under basal conditions.
Moreover, glutamate-induced increase in OCR in cortical neu-
rons was clearly reduced in ARALAR-deficient cells (146.12 
7.64% and 122.71  0.99%, p  0.05, in WT and aralar-KO
neurons, respectively; Fig. 2 I, J). Using NMDA (25 M), a non-
metabolized glutamate agonist, a similar decrease in OCR stim-
ulation was found in aralar-KO neurons (156 5% vs 127 3%
in WT and KO neurons, respectively, p 0.001).
The increase in respiration was oligomycin-sensitive. To test
whether this increase in respiration was able to compensate for
the ATP breakdown promoted by glutamate, we performed
single-cell measurements of cytosolic ATP/ADP ratio in neurons
transfected with the plasmid coding for cytosolic targeted ratio-
metric Perceval-HR (Tantama et al., 2013). As glutamate induces
an intracellular acidification (Wang et al., 1994) andPerceval-HR
fluorescence is pH-sensitive, the variations in neuronal pH were
investigated in BCECF- loaded neurons. Glutamate induced the
same acidification in wt and KO neurons (Fig. 2K, inset) and
caused a similar fall in ATP/ADP ratio in both genotypes (Fig.
2K), suggesting that the increase in respiration does not compen-
sate for glutamate-induced ATP breakdown.
Together, these results indicate that the lack of ARALAR does
not cause major changes in ionic fluxes due to glutamate stimu-
lation in cortical neurons but limits upregulation of mitochon-
drial function in response to the high workload imposed by
glutamate.We have recently observed that the rapid activation of
respiration in response toNMDAappears to be critical to prevent
delayed excitotoxicity (Rueda et al., 2015). Therefore, this sug-
gested that ARALAR deficiency would impact on the delayed
response to glutamate. To explore this possibility, we have stud-
ied the role of ARALAR in the excitotoxic paradigm in vivo and in
vitro.
Aralar hemizygote mice display an increased susceptibility to
KA-induced seizures and neuronal damage
To study the in vivo response to KA excitotoxicity, we used aralar
HT mice as aralar-KO mice only live up to 20 d. Ben-Ari et al.
(1979a, b) showed that excessive neuronal activity following KA
intraperitoneal administration, linked to epileptiform activity
(Olney et al., 1979), is closely associated with neuronal damage.
Thus, we analyzed the epileptic activity and the subsequent neu-
rodegenerative effects induced by KA inWT and aralarHTmice.
Mouse strain background determines both KA-evoked sei-
zures as well as the severity of seizure-induced damage and exci-
totoxic cell death (Schauwecker, 2011). For the SVJ129 
C57BL6 hybrid background of the aralar mice, we used a final
dose of 22.5 mg/kg KA (see administration protocol in Materials
and Methods), and the time course of the seizures was followed
for 3 h after injection. Brain histological analysis was performed 1
week after the treatment. At this dose, the administration proto-
col guaranteed the achievement of at least one seizure scored
Table 1. KA administration scheme and seizure scoresa
Seizure score
level Characteristic behavior
1 Unmoving and crouched in a corner
2 Stretched body out, tail becomes straight and rigid, ears laid back, bulging eyes
3
Repetitive head bobbing, rears into a sitting position with forepaws resting on
belly
4
Rearing and falling clonic seizures broken by periods of total stillness, jumping
clonus, running clonus
5 Continuous level 4 seizures
6
Body in clonus, no longer using limbs to maintain posture, tonic-clonic seizures,
usually precursor to death
7 Death
aMice were given an initial intraperitoneal injection of 15 mg/kg KA, which was reinforced 60 min later with a
supplemental dose that was half the initial one. Seizure recordingwas performed over 3 h. A 7 point scale was used
to rate a subject visually following systemic administration of KA (22.5 mg/kg final dose) (Schauwecker and Stew-
ard, 1997).
Table 2. Qualitative analysis of damaged regions in wild-type and Aralar HTmicea
aralar/ aralar/
Hipoccampus 3/13 9/12
Cerebral cortex 0/13 3/12
Septal nucleus 3/13 9/12
Thalamus 0/13 5/12
Hypothalamus 0/13 1/12
Endopiriform nucleus 0/13 3/12
Ectorhinal, endorhinal, perirhinal cortex 0/13 4/12
Amygdala nucleus 2/13 3/12
Cerebellum 0/13 0/12
aOneweekafter theKA treatment, brains fromWT (n
13) andaralarHT (n
12)micewere analyzed. Fluoro-Jade
B immunostaining was used for the detection of neuronal degeneration in several regions as indicated.
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Level 4 for each animal (Table 1) while maintaining overall via-
bility (one aralar HT animal died few days after the test).
A cohort of 26 adult animals (WT n
 13, aralarHT n
 13)
were used. Neither control nor aralarHTmice showed hyperex-
citability or spontaneous seizures during standard housing.
However, after KA administration, aralar HT mice showed an
enhanced seizure profile (Fig. 3A). WT mice showed a predomi-
nance of seizure score Level 2 events (Table 1; Fig. 3A) and latency
to first seizure score Level 4 event of 88.39 15.71 min and only
46.54  12.43 min for aralar HT mice (p  0.05) (Fig. 3B). In
addition to the early burst of seizures, aralarHTmice underwent
a sustained seizure profile with seizures lasting several minutes,
reaching an average crisis duration of 34 min well above WT
mice (9 min) (Fig. 3C). WT mice never showed tonic-clonic
seizure score Level 6 events and fewer number of seizure score
Level 4 and 5 than aralarHT mice (Fig. 3A).
Analysis of neuronal death showed damaged (Fluoro-Jade B)-
positive cells in different regions. Table 2 summarizes the results
obtained and regions analyzed in WT and aralar HT. Impor-
tantly, and as shown previously (Lothman andCollins, 1981), the
hippocampus was one of the most affected areas in the brain.
Representative image of hippocampus is shown in Figure 3D.
Quantitative analysis performed in the hippocampal region
showed that the number of degenerating neurons in CA1, CA2,
CA3, and DG per square millimeters was much higher in aralar
HT than in control mice (Fig. 3E–H). These results indicate that
the lack of an aralar allele increases susceptibility to KA seizures
and KA-induced neuronal damage.
Glutamate-induced cell death in hypoglycemic conditions
and upon external glutamate administration is independent
of ARALAR
We next studied the influence of ARALAR on glutamate excito-
toxicity in vitro using primary cortical neuronal cultures from
WT and aralar-KO embryos. We focused on two conditions:
hypoglycemia-induced and glutamate-induced excitotoxicity. As
shown previously, glucose deprivation leads to glutamate release
to culture media, which induces neuronal death through the ac-
tion on NMDA receptors (Kauppinen et al., 1989). Glutamate
release was the same in WT and aralar-KO cultures (1.72 0.10
and 1.38  0.08 nmol/105cell in WT and aralar-KO cultures,
respectively, Fig. 4A) and neuronal death occurred in both to a
similar extent (Fig. 4B). Administration of 5 M ()-MK-801
hydrogen maleate (MK-801), a noncompetitive inhibitor of the
NMDA receptor (Wong et al., 1986), completely blocked neuro-
toxicity and glutamate release to the culture media induced in
hypoglycemic conditions (data not shown), verifying the in-
volvement of excitotoxicity in this paradigm.
As hypoglycemia-induced excitotoxicity was not dependent
on the presence of ARALAR, we hypothesized that acute expo-
sure to 25 M glutamate in normoglycemia would reveal
ARALAR-dependent differences in excitotoxicity 24 h later. Sur-
prisingly, neuronal survival 24 h after 5 or 30 min exposure to 25
M glutamate did not differ between genotypes (Fig. 4C). Basal
neuronal survival in vitro was also the same in aralar-KO than in
control cultures (Fig. 4C). Moreover, neuronal survival in re-
sponse to increasing glutamate concentrations (5–50M)was the
same for both genotypes, except for a small difference at 5 M
glutamate (Fig. 4D). The lack of influence of ARALAR on these
various forms of in vitro glutamate excitotoxicity is in striking
contrast with the results observed in vivo. We reasoned that this
paradoxical result may be due to the utilization of alternative
energy sources in vivo, different fromglucose, the only exogenous
substrate present in vitro conditions.
A major event in glutamate excitotoxicity is the activation of
the nuclear enzyme PARP1, which uses cytosolic, but not mito-
chondrial, NAD, and thereby inhibits glycolysis at the glyceral-
dehyde 3-phosphate dehydrogenase (GA3PDH) step (Alano et
al., 2010; Kim et al., 2011;Duchen, 2012). In a scenario of block in
GA3PDH and limited pool of cytosolic pyridine nucleotides,
MAS would be dispensable, and this may explain why the pres-
ence of ARALAR does not protect against in vitro excitotoxicity.
In addition, a direct action of PAR polymers in mitochondria-
associated hexokinase1 (Andrabi et al., 2014; Fouquerel et al.,
2014) would also lead to a limitation in substrate supply. Al-
though the extent to which this happens in neurons is yet un-
known, together, these findings support the notion that ARALAR
is not protective in in vitro excitotoxicity on glucose as only en-
ergy source, due to the block of glycolysis caused by glutamate,
which makes MAS dispensable. Therefore, we have considered
that, during in vivo kainate administration, neurons may use
other energy sources whose utilization may be hampered in the
absence of ARALAR, particularly L-lactate.
Limited aerobic L-lactate utilization in ARALAR-
deficient neurons
Glucose is the obligate energy substrate for the brain. Abundant
experimental evidence, however, suggests that L-lactate is also an
important brain energy substrate in hypoxia or during high
brain activity, not a mere waste byproduct issued from anaer-
obic metabolism.
Therefore, we have studied the role of ARALAR on lactate
utilization during excitotoxicity. We first studied the effect of
L-lactate on glutamate-induced Ca2 signaling. A 30 min prein-
cubation in the presence of 15 mM glucose and 2 mM L-lactate
resulted in an increase in glutamate-induced Ca2 peak both in
WT and ARALAR-deficient neurons (Fig. 5A,B; compare with
Fig. 2A,B). Glutamate-induced increase in mitochondrial Ca2
was not modified by L-lactate preincubation and was the same in
both genotypes (Fig. 5D–F; compare with Fig. 2D–F). This result
is consistent with those of Yang et al. (2014) who found that high
concentrations of L-lactate (2.5 mM) potentiate over time the
effects of glutamate, greatly amplifying glutamate-induced in-
crease in cytosolic Ca2. These effects required the uptake of
4
(Figure legend continued.) potential was analyzed using the single-wavelength fluorescent
indicator Rhodamine 123 (Rhod-123) in the quench mode. Mitochondrial depolarization is
observed as an increase in fluorescence. The 100M glutamate in the presence or the absence
of 2 mM Ca 2 in 2.5 mM glucose media was added as indicated. Data correspond to 10
independent experiments in WT and aralar-KO primary neuronal cultures. Glu, Glutamate; Oli,
oligomycin. H, Changes in cytosolic Na in SBFI-loaded neurons by stimulation with 100M
glutamate (100M Glu) in 15 mM glucose and 2 mM Ca 2 media. Normalized ratio is repre-
sented. Data correspond to 28 neurons from two independent experiments (blue line, WT) and
75 neurons in four independent experiments (red line, aralar-KO), Ouabain (Oua; 0.1M), and
monensin (Mon; 10mM)were added for equilibration of extracellular and intracellular [Na] at
the end of the experiments. I, Stimulation of OCR upon 50M glutamate (Glu 50) in WT and
aralar-KO neurons in 2.5 mM glucose and 2 mM Ca 2 media. A, 50 M glutamate. B, 6 M
oligomycin. C, 0.5 mM DNP. D, 1 M/1 M antimycin/rotenone. n
 33–42 from 11 to 18
independent experiments in WT and n
 25–34 from 9 to 16 aralar-KO primary neuronal
cultures. J, Stimulation of respiration (as percentage of basal values).K, Cytosolic ATP/ADP ratio
(Perceval-HR occupancy, GFP/Venus ratio fluorescence) was measured in WT and aralar-KO
neurons 24 h after Perceval-HR transfection. Neurons were stimulatedwith 100M glutamate
in 15mMglucose and 2mMCa 2medium. Data aremean SEM (5–16 neurons and indepen-
dent platings). Inset, Variations in intracellular pH (mean SEM) determined in BCECF-loaded
neurons in WT and KO neurons, under the same conditions of the Perceval-HR experiments.
*p 0.05 (Student’s t test). **p 0.01 (Student’s t test).
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L-lactate, as they were blocked by an inhibitor of the L-lactate
transporter (UK5099). Whether this effect of L-lactate involves
L-lactate signaling through a G-protein-coupled receptor,
GPR81/HCA1 (Lauritzen et al., 2014; Mosienko et al., 2015), to
downregulate cell cAMP levels is yet unknown.
The effects of L-lactate on glutamate-induced increase inOCR
were next studied inWT (Fig. 5G) and aralar-KO (Fig. 5H) neu-
rons incubated in the presence of 2.5 mM glucose alone, or sup-
plemented with 2 mM L-lactate. Pyruvate (2 mM) was used as a
substrate independent of ARALAR-MAS activity. The presence
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Figure 3. Increased susceptibility to KA and higher neuronal degeneration in aralar HTmice. A, Progression of behavioral changes after systemic KA administration (22.5 mg/kg i.p., final dose)
inWTandaralarHT following the score Table1over 3h.B, Latency to the first Level 4 event calculated fromthe timeofKA initial administration.C, Total timeperforming seizuresduring the complete
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0.05; **p 0.01. D, Fluoro-Jade B immunostaining in a representative aralar HT brain. E–H, Degenerating Fluoro JadeB-positive neurons were counted using ImageJ and referred to area of the
hippocampal subfields in square millimeters. Data are mean SEM. *p 0.05 (Student’s t test). **p 0.01 (Student’s t test).
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of these additional substrates did not change the basal respiratory
rate or apparent respiratory control ratio, which reflects the con-
tribution of ATP synthesis and proton leak to the OCR (results
not shown) but the presence of pyruvate increasedmitochondrial
uncoupled respiration in both genotypes (results not shown). As
shown before, aralar-KO neurons had a decreased OCR in the
presence of glucose as only substrate, which remained lower than
control neurons also when L-lactate and pyruvate were supplied
(data not shown).
D-Lactate or pyruvate supply in the presence of 2.5mMglucose
enhanced the initial glutamate-stimulation of OCR in WT cul-
tures (Fig. 5G,I). This was matched by an increase in ATP pro-
duction, as indicated by the smaller decrease in the ATP/ADP
ratio upon glutamate addition when 2 mM L-lactate was supplied
(Fig. 5J). However, L-lactate had a much smaller effect on the fall
of the ATP/ADP ratio in aralar-KO neurons (Fig. 5J), even
though intracellular pH acidification was the same in both geno-
types (Fig. 5J, inset), and no effect on glutamate-stimulated res-
piration (Fig. 5H, I), which remained much smaller than in
control neurons. The inability of L-lactate to sustain glutamate-
stimulated respiration strikingly contrasts with the effect of
pyruvate supplementation, which greatly increased glutamate-
stimulated respiration in aralar-KO cultures (Fig. 5H, I).
These results indicate that, in this high-energy demanding
state, glycolysis and L-lactate utilization bymitochondria, both of
which requireMAS, are unable tomeet the demand for substrates
in mitochondria from aralar-KO neurons, whereas the pyruvate
supply does. They also confirm that L-lactate utilization by mito-
chondria is completely dependent on MAS and ARALAR. To-
gether, the results indicate that most of the energy effects of
L-lactate are lost in aralar-KO neurons, particularly those involv-
ing mitochondrial function. However, L-lactate potentiation of
glutamate-induced increase in cytosolic calcium is maintained in
aralar-KO neurons, suggesting that it does not require L-lactate
effects on mitochondrial metabolism.
Effects of L-lactate on survival and oxidative stress of
ARALAR-deficient primary neuronal cultures challenged
with exogenous glutamate
To test whether the exogenous L-lactate confers resistance to glu-
tamate excitotoxicity through a mechanism requiring ARALAR-
MAS, we have studied the effect of L-lactate (and pyruvate) in
addition to glucose on in vitro glutamate excitotoxicity. Figure 6
shows that the presence of 10 mM L-lactate in hypoglycemic con-
ditions (Fig. 6A,B) or during exposure to 25 M glutamate (Fig.
6C) confers amarked resistance to cell death in control, but not in
aralar-KO neurons (Fig. 6B,C), whereas 2 mM pyruvate, whose
utilization does not require MAS, protects both types of neurons
(Fig. 6C).
In vitro, any L-lactate generated by cultured neurons rapidly
diffuses out into the cell culture medium promoting a negligible
intracellular to extracellular volume ratio. Moreover, in our cel-
lular cultures, astrocytes are quite scarce so the supply of lactate
from astrocytes to neurons is inconsiderable. Thus, in normogly-
cemic conditions, it may be assumed that glucose is the sole
substrate, and endogenous lactate has an irrelevant metabolic
impact.
Glutamate induces the production of superoxide and other
reactive oxygen species (ROS) through different routes (Nicholls,
2008; Brennan-Minnella et al., 2013), and ROS scavengers pro-
tect against excitotoxic cell death (Vergun et al., 2001). Oxidative
stress causes the appearance of oxidized nucleosides, particularly
8-OHdG in nuclear and mitochondrial DNA, which can be de-
tected by 8-OHdG antibodies. Immunofluorescence and confo-
cal microscopy were used to recognize 8-OHdG using selective
mitochondria versus nucleus labeling. Thirty minute 100 M
glutamate-exposure induced an early appearance of 8-OHdG in
mitochondria (assessed by colocalization with anti Mn-SOD an-
tibodies) in both WT and aralar-KO neurons (Fig. 6D,F). Glu-
tamate induced 8-OHdG staining in nuclei (Fig. 6E) as judged
from colabeling with TOPRO-3 (Fig. 6D,F) was clearly weaker
than that in mitochondria (Fig. 6G). This could reflect a specific
increase in ROS levels in neuronal mitochondrial during gluta-
mate exposure together with an enhanced vulnerability of mito-
chondrial versus nuclear DNA to oxidative damage (Barja and
Herrero, 2000).
Mitochondrial 8-OHdG staining was increased after glutamate
exposure both inWT in aralar-KOneurons (Fig. 6D–F), suggesting
that, even though stimulation of OCR is lower in aralar-KO neu-
rons, no difference in mitochondrial ROS-mediated damage to
DNAoccurs after glutamate exposure. Interestingly, 10mML-lactate
significantlyprotected fromglutamate-induced8-OHdGlabelingof
mitochondrial DNA in WT but not in aralar-KO neurons (Fig.
6D,F,G).Wehavepreviously shown that the striatum, a particularly
oxidative stress-sensitivebrainregion,undergoesaprominent rise in
the GSSG/GSH ratio in aralar KO mice, which was attributed to a
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limitedNADHformation inmitochondria, andsubsequent reduced
activityof thedetoxifying system(NADH-NADPtranshydrogenase,
GSH reductase, and peroxidase) (Llorente-Folch et al., 2013). Simi-
larly, deficiency in L-lactate utilization through ARALAR-MAS ac-
tivity might limit mitochondrial NADH formation and jeopardize
the ROS detoxifying capacity as previously observed in striatum in
aralar-KO brain (Llorente-Folch et al., 2013).
Discussion
Glutamate, the main excitatory neurotransmitter in brain, im-
poses a high workload in cerebral cortical neurons, mostly due to
Na entry. Neuronal respiration is stimulated in response to this
workload and stimulation requires the activity of MAS.
In the present work, we report that the lack of ARALAR does
not lead to major differences in ionic fluxes due to glutamate
stimulation in cortical neurons, but it results in a substantial
failure to activate glutamate-stimulated respiration. Indeed, the
presence of ARALAR allows a larger response to glutamate in
terms of upregulation of respiration. However, contrary to our
initial expectations, ARALAR deficiency does not aggravate exci-
totoxic neuronal death under hypoglycemia, when glucose me-
tabolism must be stopped, or in the presence of glucose, but it
does when L-lactate is present as an additional source. As the role
of ARALAR-MAS is to oxidize cytosolic NADH in mitochondria
andmaintain oxidative glucose utilization, halting glucose use in
hypoglycemia explains why the lack of ARALAR has no influence
on glutamate release or glutamate excitotoxicity. But it does not
explain why it has no influence when glucose is present.
A possible explanation for these findings lies on the mecha-
nism of neuronal death triggered by glutamate, which ends up in
energetic failure (Nicholls et al., 2007; Duchen, 2012; Rodriguez-
Rodriguez et al., 2013). It involves the early activation of the
nuclear PARP1 (Zhang et al., 1994), which cleaves NAD to
nicotinamide and ADP-ribose and couples one or more ADP-
ribose units to acceptor proteins. Loss of NAD is one of the
reasons why ARALAR-MAS may become dispensable in gluta-
mate excitotoxicity. Cytosolic NAD loss may lead to a block of
glycolysis at the level of the only enzyme of the pathway, which
requires NAD and the operation of MAS, GA3PDH1 (Alano et
al., 2010; Kim et al., 2011; Duchen, 2012), making MAS dispens-
able under that condition. In axons, NAD destruction may be
also caused by SARM1 activation (Gerdts et al., 2015).
PAR polymers are rapidly released to the cytosol and other
cellular compartments and have a direct action on mitochondria
leading to a fall in mitochondrial and cytosolic ATP and a de-
crease inOCR (Rueda et al., 2015). The fall inmitochondrial ATP
is partly counteracted by the entry of adenine nucleotides in mi-
tochondria through the mitochondrial carrier of ATP-Mg/Pi,
SCaMC3 (Rueda et al., 2015). PAR also inhibits mitochondria-
associated hexokinase1, leading to a block in glycolysis (Andrabi
et al., 2014; Fouquerel et al., 2014) and, consequently, substrate
supply.
Another explanation for the transient nature of glutamate-
stimulated respiration lies on the counteracting effects of the in-
crease in matrix Ca2 caused by glutamate. Matrix Ca2 increases
respiration by activation of mitochondrial dehydrogenases but also
lowers matrix -ketoglutarate (KG) levels (due to Ca2-
dependentdropof theKmforKGofKGdehydrogenase)andthus
the activity of the OGC, the second member of MAS, causing an
inhibition of MAS (Pardo et al., 2006; Contreras and Satru´ste-
gui, 2009; Satru´stegui and Bak, 2015) opposing the increase in
respiration.
The combined and not mutually exclusive effects of NAD
loss, matrix Ca2-dependent inhibition of OGC-MAS, limited
respiratory response, and reduced glucose phosphorylation and
substrate supply may result in a metabolic limitation in which
ARALAR-MAS is probably dispensable.
D-Lactate is an alternative energy substrate for the brain,
whichmay be used by neuronswhen glucose use is impaired, as in
glutamate excitotoxicity. It can be a preferential substrate partic-
ularly in conditions of hypoxia (Schurr et al., 1997a) and during
periods of high activity (Tildon et al., 1993; Pellerin et al., 1998;
Kasischke et al., 2004; Pellerin and Magistretti, 2004), as con-
firmed in vivo (Smith et al., 2003; Serres et al., 2004; Boumezbeur
et al., 2010); and it can spare cerebral glucose in the injured
human brain (Bouzat et al., 2014).
In the brain, astrocytes are the main source of L-lactate, and
glutamate stimulation enhances glucose transport (Loaiza et al.,
2003), utilization (Pellerin and Magistretti, 1994, 1996; Porras et
al., 2008), and lactate production in astrocytes. Together with the
activation of astrocytic glycogen degradation by glutamate (Shul-
man et al., 2001), this may explain the large increase in local
extracellular lactate that follows cortical activation (Hu andWil-
son, 1997) and subconvulsive kainate administration (Walls et
al., 2014). L-Lactate acts as a buffer between glycolysis and oxida-
tive metabolism and it is exchanged as a fuel between cells and
tissues with different glycolytic and oxidative rates. As L-lactate
utilization bymitochondria in neurons requires cytosolic NADH
oxidation throughMAS, ARALAR-deficient neuronsmay be un-
able to use it, which may lead to cell demise.
Our results clearly show that L-lactate was able to rescue from
glutamate excitotoxicity control, but not ARALAR-deficient neu-
rons (Fig. 6). Both L-lactate andpyruvate potentiated the respiratory
response to glutamate in control neurons, but only pyruvate, and
not L-lactate, supplementation increased glutamate-stimulated res-
piration of aralar-KO neurons to the level of control neurons, con-
sistent with an energetic failure at the level of pyruvate supply to
mitochondria in these neurons. L-Lactate metabolism bypasses the
PARP-1blockof the hexokinase1 step; therefore, substrate supply to
mitochondria will be maintained, even if other events downstream
of PARP-1 activation remain unchanged. This explains the effect of
L-lactate supply in preventing the large decrease in the ATP/ADP
4
(Figure legend continued.) average (thick black trace) are shown. Horizontal lines indicate
cytosolic Ca 2 increase in the absence of L-lactate for each experimental condition. No differ-
ences were observed comparing genotypes. D–F, Corresponding data in neurons transfected
with 4mtD3cpv probe to determine changes inmitochondrial Ca 2 in 2.5mMglucose and2mM
Ca 2media in the presence of 2mM L-lactate. Recording from16 and 17 transfected cells, in 11
and 9 independent experiments, in WT and aralar-KO primary neuronal cultures, respectively,
for mitochondrial Ca 2 imaging. Individual cell recordings (gray) and average (thick black
trace) are shown. G, H, Effects of additional substrates, 2 mM L-lactate (L2) and 2 mM pyruvate
(P2), in the presence of 2.5 mM glucose, on glutamate-induced stimulation of mitochondrial
respiration using upon 25M glutamate (Glu 25). n
 4–6 from two or three independent
experiments fromcontrol andaralar-KOprimary neuronal cultures.*p0.05 (Student’s t test).
***p 0.001 (Student’s t test). Mitochondrial function in neurons was determined through
sequential additionof (A) vehicle/glutamate, (B) 6Moligomycin (Oli), (C) 0.5mMDNP, and (D)
1 M antimycin/1 M rotenone (A/R) where indicated by the dashed line using the XF24
extracellular flux analyzer. I, Stimulation of respiration (as percentage of basal values). J, Cyto-
solic ATP/ADP ratio (Perceval-HR occupancy, GFP/Venus ratio fluorescence) was measured in
WT and aralar-KO neurons 24 h after Perceval-HR transfection, and stimulated with 100 M
glutamate in 15 mM glucose and 2 mM Ca 2medium in the presence of 2 mM L-lactate. Quan-
tification 300 s after glutamate is shown. Data are from 5 to 12 neurons and two or three
independent platings. *p 0.05 (Student’s t test). Inset, Variations in intracellular pH, deter-
mined in BCECF-loaded neurons in WT and KO neurons, under the same conditions of the
Perceval-HR experiments.
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Figure 6. Effects of L-lactate on survival and oxidative stress of ARALAR-deficient primary neuronal cultures challenged with exogenous glutamate. A, Increase in glutamate released to the
neuronal culture media, 24 h after treatment in conditions of 10 mM L-lactate under glucose deprivation in WT and aralar-KO cultures. B, Cellular viability was evaluated 24 h after maintaining
cultures for 6 h in the previously mentioned condition. Data are calculated as an increase in percentage of dead cells, compared with control condition with 5.0 mM glucose using the calcein-AM/
propidium iodidemethod. C, Cortical cell cultureswere pretreatedwith 10mM L-lactate or 2mM pyruvate 30min before 5min exposure to 25M glutamate andmaintained for 24 h in the presence
of L-lactateorpyruvate.Dataareexpressedaspercentageofdead cells, PI/(CLPI), under control treatment (Ctr), glutamateexposure (Glu25), glutamateplus L-lactate (Glu25Lac), or glutamate
plus pyruvate (Glu25 pyr). Data are mean SEM from three independent experiments. *p 0.05 (one-way ANOVA followed by Student-Newman-Keuls t test). **p 0.01 (one-way ANOVA
followedbyStudent-Newman-Keuls t test).D–G, Detectionof 8-OHdG immunostaining inmitochondrial andnuclearDNA inducedby100Mglutamate exposure for 30minaloneor in thepresence
of 10mM L-lactate. Photomicrographs representative for control (CTR), glutamate (Glu), or glutamate plus L-lactate (Glu Lac) conditions are shown in control (D) and aralar-KO (F). Coimmunos-
tainingwasperformedusing TOPRO-3 (nuclearmarker) orMn-SOD (mitochondrialmarker) andquantified inE andG, respectively, to elucidate theprimaryDNAdamage induced in our experimental
conditions. Integrated and average fluorescence intensity was calculated using theMetaMorph program. n
 177–349, or 218–304 cells per condition, inWT and aralar-KO cultures, respectively.
*p0.05 (ANOVA followedby followedbyStudent-Newman-Keuls t test). **p0.01 (ANOVA followedby followedbyStudent-Newman-Keuls t test). ***p0.001 (ANOVA followedby followed
by Student-Newman-Keuls t test). n.s, Not significant.
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ratio caused by glutamate in controls, but not in ARALAR-deficient
neurons.
We have also found that L-lactate supply markedly reduces
glutamate-induced mitochondrial accumulation of 8-oxogu-
anosine, a marker of ROS production in control, but not in
aralar-KO neurons. L-Lactate metabolism supplies redox equiv-
alents in the cytosol and, through the action of ARALAR-MAS,
also to themitochondrialmatrix. Glutathione ismore oxidized in
the striatum of aralar-KO mice than in that of controls, possibly
due to the inability to transfer redox equivalents to themitochon-
drial matrix in ARALAR deficiency (Llorente-Folch et al., 2013).
In the paradigm of glutamate excitotoxicity, failure to transfer
L-lactate-derived reducing equivalents to mitochondria also ex-
plains lack of protection by L-lactate in aralar-KO neurons.
We also noted that L-lactate potentiated glutamate signaling,
resulting in a larger glutamate-stimulated [Ca2]i increase.
L-Lactate has been shown to potentiate NMDA receptor activity
and its downstream signaling cascade leading to the expression of
plasticity related genes, such asArc, c-Fos, andZif268 (Yang et al.,
2014), and L-lactate uptake into neurons is required for these
effects. However, as the increase in glutamate-induced [Ca2]i
signals by L-lactate were observed both on control and aralar-KO
neurons, we conclude that they do not require L-lactate metabo-
lism inmitochondria, and that they are probably unrelated to the
protection by L-lactate against excitotoxicity.
Finally, we report that, in vivo, the loss of a single aralar allele
of in the aralar/ mouse increases KA-induced seizures and
neuronal damage. As there are abundant data indicating that
L-lactate levels increase during seizures and L-lactate consump-
tion by neurons also increases (Ros et al., 2001), these results are
probably due to inefficient L-lactate utilization in the aralar HT
mice. This would entail that, in these mice, ARALAR levels limit
the operation of the shuttle in vivo. Indeed, there is evidence that
this is the case: (1) brain aspartate levels, which depend on
ARALAR activity, are significantly lower than controls at 20 d
postnatal (Jalil et al., 2005); (2) brain N-acetyl-aspartate peak
determined in vivoby 1H-NMRspectroscopy is also reducedwith
respect to control (unpublished results); (3) respiration of brain
mitochondria on malate plus glutamate andMAS activity recon-
stituted in skeletal muscle, and brainmitochondria is halved with
respect to control (Jalil et al., 2005); and (4) N-acetyl-aspartate
levels in cultured neurons are reduced with respect to control
(Jalil et al., 2005). Although other explanations cannot be ruled
out, the results suggest that L-lactate utilization during seizures
requires maximal ARALAR activity to efficiently transfer cytoso-
lic reducing equivalents from NADH to mitochondria. On these
grounds, it may be suggested that other situations requiring
L-lactate metabolism by neurons will be also affected by partial
ARALAR deficiency.
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